SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Silvio Danese, Lucine Vuitton, Laurent Peyrin-Biroulet, Biologic agents for IBD: practical insights, Nature Reviews Gastroenterology & Hepatology, 2015, 12, 9, 537

    CrossRef

  2. 2
    Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet, Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, 2014, 12, 8, 1246

    CrossRef

  3. 3
    Lisa M. Sedger, Michael F. McDermott, TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future, Cytokine & Growth Factor Reviews, 2014, 25, 4, 453

    CrossRef

  4. 4
    Gordon W. Moran, Marie-France Dubeau, Gilaad G. Kaplan, Remo Panaccione, Subrata Ghosh, The Increasing Weight of Crohnʼs Disease Subjects in Clinical Trials, Inflammatory Bowel Diseases, 2013, 19, 13, 2949

    CrossRef

  5. 5
    Yulia Vugmeyster, John Harrold, Xin Xu, Absorption, Distribution, Metabolism, and Excretion (ADME) Studies of Biotherapeutics for Autoimmune and Inflammatory Conditions, The AAPS Journal, 2012, 14, 4, 714

    CrossRef

  6. You have free access to this content6
    Anne Christine W. Vos, Manon E. Wildenberg, Ingrid Arijs, Marjolijn Duijvestein, Auke P. Verhaar, Gert de Hertogh, Séverine Vermeire, Paul Rutgeerts, Gijs R. van den Brink, Daniel W. Hommes, Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro, Inflammatory Bowel Diseases, 2012, 18, 3
  7. 7
    Anne Christine W. Vos, Manon E. Wildenberg, Marjolijn Duijvestein, Auke P. Verhaar, Gijs R. van den Brink, Daniel W. Hommes, Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner, Gastroenterology, 2011, 140, 1, 221

    CrossRef

  8. 8
    Clémentine Perrier, Paul Rutgeerts, Cytokine blockade in inflammatory bowel diseases, Immunotherapy, 2011, 3, 11, 1341

    CrossRef

  9. 9
    Nilanjan Ghosh, Rituparna Chaki, Vivekananda Mandal, G. David Lin, Subhash C. Mandal, Mechanisms and Efficacy of Immunobiologic Therapies for Inflammatory Bowel Diseases, International Reviews of Immunology, 2010, 29, 1, 4

    CrossRef

  10. 10
    Inès Zidi, Souhir Mestiri, Aghleb Bartegi, Nidhal Ben Amor, TNF-α and its inhibitors in cancer, Medical Oncology, 2010, 27, 2, 185

    CrossRef

  11. 11
    Laurent Peyrin–Biroulet, Pierre Deltenre, Nicolas de Suray, Julien Branche, William J. Sandborn, Jean–Frédéric Colombel, Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials, Clinical Gastroenterology and Hepatology, 2008, 6, 6, 644

    CrossRef

  12. 12
    Małgorzata Myśliwiec, Anna Balcerska, Katarzyna Zorena, Jolanta Myśliwska, Piotr Wiśniewski, Immunologic and Biochemical Factors of Coincident Celiac Disease and Type 1 Diabetes Mellitus in Children, Pediatric Research, 2008, 64, 6, 677

    CrossRef

  13. 13
    A. Noble, R. Baldassano, P. Mamula, Novel therapeutic options in the inflammatory bowel disease world, Digestive and Liver Disease, 2008, 40, 1, 22

    CrossRef

  14. 14
    J. SEIDERER, S. BRAND, J. DAMBACHER, S. PFENNIG, M. JÜRGENS, B. GÖKE, T. OCHSENKÜHN, Adalimumab in patients with Crohn’s disease – safety and efficacy in an open-label single centre study, Alimentary Pharmacology & Therapeutics, 2007, 25, 7
  15. 15
    Mark T. Osterman, Gary R. Lichtenstein, Current and future anti-TNF therapy for inflammatory bowel disease, Current Treatment Options in Gastroenterology, 2007, 10, 3, 195

    CrossRef

  16. 16
    Daniel C Baumgart, William J Sandborn, Inflammatory bowel disease: clinical aspects and established and evolving therapies, The Lancet, 2007, 369, 9573, 1641

    CrossRef

  17. 17
    Trevor A Winter, William J Sandborn, Willem JS de Villiers, Stefan Schreiber, Treatment of Crohn’s disease with certolizumab pegol, Expert Review of Clinical Immunology, 2007, 3, 5, 683

    CrossRef

  18. 18
    Livia Biancone, Emma Calabrese, Carmelina Petruzziello, Francesco Pallone, Treatment with biologic therapies and the risk of cancer in patients with IBD, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 2, 78

    CrossRef

  19. 19
    Pieter C. F. Stokkers, Daniel W. Hommes, Novel biological therapies for inflammatory bowel disease, Current Treatment Options in Gastroenterology, 2006, 9, 3, 201

    CrossRef

  20. 20
    Brian G Feagan, John WD McDonald, Crohn's Disease,
  21. 21
    Brian W Behm, Stephen J Bickston, Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease, The Cochrane Library,